1. Home
  2. XBIT vs CULP Comparison

XBIT vs CULP Comparison

Compare XBIT & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.95

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Logo Culp Inc.

CULP

Culp Inc.

N/A

Current Price

$3.47

Market Cap

46.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
CULP
Founded
2005
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
57.6M
46.2M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
XBIT
CULP
Price
$1.95
$3.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 82.6K
40.9K
Earning Date
11-12-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.06
EPS
N/A
★ 0.47
Revenue
N/A
★ $203,482,000.00
Revenue This Year
N/A
$3.15
Revenue Next Year
$30.47
$1.77
P/E Ratio
★ N/A
$7.47
Revenue Growth
N/A
★ N/A
52 Week Low
$1.80
$2.70
52 Week High
$2.73
$4.17

Technical Indicators

Market Signals
Indicator
XBIT
CULP
Relative Strength Index (RSI) 45.36 43.36
Support Level $1.83 $3.46
Resistance Level $2.42 $3.48
Average True Range (ATR) 0.11 0.17
MACD 0.01 -0.02
Stochastic Oscillator 45.45 37.41

Price Performance

Historical Comparison
XBIT
CULP

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics, sewn covers for mattresses, foundations, and other bedding products, and upholstery fabrics, including cut and sewn kits, for residential, commercial, and hospitality furniture and other applications. It markets fabrics produced at its manufacturing facilities and fabrics sourced through other suppliers to bedding and furniture companies. Its products serve the bedding, residential furnishings, commercial furnishings, and hospitality furnishings markets. Its segments are: Bedding and Upholstery, with Bedding generating the maximum revenue. The Bedding segment supplies the bedding market, comprising mattress sets and bedding accessory products. It generates the maximum revenue from the United States.

Share on Social Networks: